MEDICATION LIST ASSESSMENT IN SPANISH HOSPITAL EMERGENCY DEPARTMENTS
Por:
Parejo, MIB, Borrego, AMJ, Ruiz, JA, Monjo, MC, Garcia-Pelaez, M, Hernanz, BC, Hernandez, MAC, Fernandez, MIC, Riera, MP, Sanchez, RG, Sanchez, LG, Lopez, CV, Echeverria, MDM, Serrano, PM
Publicada:
1 abr 2015
Resumen:
Background: Medication errors lead to morbidity and mortality among emergency department (ED) patients. An inaccurate medication history is one of the underlying causes of these errors. Objectives: This study was performed to determine the prevalence of patients with discrepancies between the medical list information contained in the clinical history compiled on admission to the ED and the list of medications patients are actually taking, to characterize the discrepancies found, and to analyze whether certain factors are associated with the risk of discrepancies. Methods: We conducted a cross-sectional, descriptive, observational, multicenter study with an analytic component in the EDs of 11 hospitals in Spain. We compared pharmacist-obtained medication lists (PML) with ED-obtained medication lists (EDML). Discrepancy was defined as one or more differences (in drug or dosage or route of administration) between the EDML and PML. The endpoints were the proportion of patients with discrepancies in their home medical lists, and the prevalence of certain factors among patients with discrepancies and those without. Results: We detected 1476 discrepancies in 387 patients; no discrepancies were found in 20.7%. The most frequent discrepancies involved incomplete information (44.2%) and omission (41.8%). In the bivariate analysis, age, number of medications, and Charlson comorbidity score were significantly associated with discrepancy. In the multi-variate analysis, number of medications and hospital were the variables associated with discrepancy. Conclusions: The EDML differed from the list of medications patients were actually taking in 79.3% of cases. Incomplete information and omission were the most frequent discrepancies. Age, number of medications, and comorbidities were related to the risk of discrepancies. (C) 2015 Elsevier Inc.
Filiaciones:
Parejo, MIB:
Minist Hlth, Cordoba, Spain
Borrego, AMJ:
Hosp Santa Creu & Sant Pau, Dept Pharm, Barcelona, Spain
Ruiz, JA:
Fundacio St Hosp, La Seu Durgell, Spain
Monjo, MC:
Hosp Son Espases, Dept Pharm, Palma De Mallorca, Spain
Garcia-Pelaez, M:
Corp Sanitaria Parc Tauli, Dept Pharm, Sabadell 08208, Spain
Hernanz, BC:
Hosp Son Llatzer Palma Mallorca, Dept Pharm, Palma de Mallorca, Spain
Hernandez, MAC:
Univ Hosp Virgen de las Nieves, Dept Pharm, Granada, Spain
Fernandez, MIC:
Univ Hosp Virgen de las Nieves, Dept Pharm, Granada, Spain
Riera, MP:
Hosp Formentera, Dept Pharm, Ibiza, Spain
Hosp Can Misses, Ibiza, Spain
Sanchez, RG:
Univ Hosp Gregorio Maranon, Dept Pharm, Madrid, Spain
Sanchez, LG:
Badalona Serv Assitencials, Dept Pharm, Badalona, Spain
Lopez, CV:
Univ Hosp Meixoeiro, Dept Pharm, Vigo, Spain
Echeverria, MDM:
Univ Hosp Donostia, Dept Pharm, Donostia San Sebastian, Spain
Serrano, PM:
Univ Hosp Alicante, Dept Pharm, Alicante, Spain
|